{"schema_version":"secwatch.filing_event.v1","accession":"0000721371-26-000037","form_type":"8-K","ticker":"CAH","cik":"0000721371","company_name":"CARDINAL HEALTH INC","filed_at":"2026-08-11T10:47:32+00:00","discovered_at":"2026-08-11T10:50:00.365912+00:00","generated_at":"2026-08-11T10:50:08.719732+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Cardinal Health Q4 revenue up 6% to $63.7B; FY26 non-GAAP EPS $11.26, up 37%","bullets":["Q4 revenue $63.7B (+6% YoY); GAAP diluted EPS $1.70 (+70%); non-GAAP EPS $2.91 (+40%), incl. $0.31 IEEPA refund.","FY26 revenue $254.2B (+14%); non-GAAP EPS $11.26 (+37%); excluding IEEPA refund, EPS $10.95 (+33%).","Board approved $5.0B incremental buyback; FY26 repurchases totaled $1.4B, new authorization $6.4B.","FY27 guidance: non-GAAP EPS $12.40-$12.60 (+13% to +15%); segment profit growth guided 8-18%.","Pharma segment profit +21%; GMPD profit $150M on IEEPA refunds; dividend $0.5158/share payable Oct 15."],"urls":{"canonical":"https://secwatch.observer/filing/0000721371-26-000037","json":"https://secwatch.observer/filing/0000721371-26-000037.json","markdown":"https://secwatch.observer/filing/0000721371-26-000037.md","text":"https://secwatch.observer/filing/0000721371-26-000037.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/721371/000072137126000037/0000721371-26-000037-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/721371/000072137126000037/cah-20260811.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-11T10:50:08.719732+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}